tiprankstipranks
Advertisement
Advertisement
Alkermes sinks 5% to $50.05 following Q2 report
PremiumThe FlyAlkermes sinks 5% to $50.05 following Q2 report
15d ago
Alkermes reaffirms FY26 revenue view $1.73B-$1.84B, consensus $1.81B
Premium
The Fly
Alkermes reaffirms FY26 revenue view $1.73B-$1.84B, consensus $1.81B
15d ago
Alkermes reports Q2 revenue $496.0M, consensus $457.36M
Premium
The Fly
Alkermes reports Q2 revenue $496.0M, consensus $457.36M
15d ago
Alkermes price target raised to $63 from $45 at Stifel
PremiumThe FlyAlkermes price target raised to $63 from $45 at Stifel
23d ago
American Express, Biogen upgraded: Wall Street’s top analyst calls
Premium
The Fly
American Express, Biogen upgraded: Wall Street’s top analyst calls
1M ago
Thome Reiterates Buy on Encouraging Alixorexton Data and Reduced Oxybate Competition, Lifting Price Target to $57
Premium
Ratings
Thome Reiterates Buy on Encouraging Alixorexton Data and Reduced Oxybate Competition, Lifting Price Target to $57
1M ago
Alkermes price target raised to $65 from $53 at Mizuho
PremiumThe FlyAlkermes price target raised to $65 from $53 at Mizuho
1M ago
Adobe downgraded, Roblox upgraded: Wall Street’s top analyst calls
Premium
The Fly
Adobe downgraded, Roblox upgraded: Wall Street’s top analyst calls
1M ago
Alkermes downgraded to Underperform from Neutral at BofA
Premium
The Fly
Alkermes downgraded to Underperform from Neutral at BofA
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100